IMpower110 Clinical Trial Results | TECENTRIQ® (atezolizumab),Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 | New England Journal of Medicine,Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials | Nature Medicine,LMS parameters, percentile, and Z-score growth curves for axial length in Chinese schoolchildren in Wuhan | Scientific Reports,Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC | New England Journal of Medicine,